Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 57

1.

Randomized phase II trial of cixutumumab alone or with cetuximab for refractory recurrent/metastatic head and neck squamous cell carcinoma.

Ferrarotto R, William WN Jr, Tseng JE, Marur S, Shin DM, Murphy B, Cohen EEW, Thomas CY, Willey R, Cosaert J, Harun N, Jack Lee J, Wistuba IW, Haddad RI, Glisson BS.

Oral Oncol. 2018 Jul;82:83-90. doi: 10.1016/j.oraloncology.2018.05.014. Epub 2018 May 19.

PMID:
29909907
2.

A Phase II Study of Dovitinib in Patients with Recurrent or Metastatic Adenoid Cystic Carcinoma.

Dillon PM, Petroni GR, Horton BJ, Moskaluk CA, Fracasso PM, Douvas MG, Varhegyi N, Zaja-Milatovic S, Thomas CY.

Clin Cancer Res. 2017 Aug 1;23(15):4138-4145. doi: 10.1158/1078-0432.CCR-16-2942. Epub 2017 Apr 4.

3.

Adenoid cystic carcinoma: A review of recent advances, molecular targets, and clinical trials.

Dillon PM, Chakraborty S, Moskaluk CA, Joshi PJ, Thomas CY.

Head Neck. 2016 Apr;38(4):620-7. doi: 10.1002/hed.23925. Epub 2015 Jun 16. Review.

4.

Trend in vancomycin susceptibility and correlation with molecular characteristics of methicillin-resistant Staphylococcus aureus causing invasive infections in Taiwan: results from the Tigecycline in vitro Surveillance in Taiwan (TIST) study, 2006-2010.

Tsao SM, Wang WY, Ko WC, Huang CH, Lu CT, Chuang YC, Liu CY, Liao CH, Chen YS, Liu YC, Chen WY, Jang TN, Lin HC, Chen CM, Shi ZY, Pan SC, Yang JL, Kung HC, Liu CE, Cheng YJ, Liu JW, Sun W, Wang LS, Yu KW, Chiang PC, Lee MH, Lee CM, Hsu GJ, Chen YH, Lu PL, Thomas CY, Hsueh PR.

Diagn Microbiol Infect Dis. 2014 Oct;80(2):162-7. doi: 10.1016/j.diagmicrobio.2014.06.007. Epub 2014 Jun 21.

PMID:
25053202
5.

Impact of renal function on eligibility for chemotherapy and survival in patients who have undergone radical nephro-ureterectomy.

Thomas CY, Hemal AK.

BJU Int. 2013 Aug;112(4):425-6. doi: 10.1111/j.1464-410X.2012.11755.x. No abstract available.

6.

Genetic markers associated with early cancer-specific mortality following prostatectomy.

Liu W, Xie CC, Thomas CY, Kim ST, Lindberg J, Egevad L, Wang Z, Zhang Z, Sun J, Sun J, Koty PP, Kader AK, Cramer SD, Bova GS, Zheng SL, Grönberg H, Isaacs WB, Xu J.

Cancer. 2013 Jul 1;119(13):2405-12. doi: 10.1002/cncr.27954. Epub 2013 Apr 22.

7.

Activation of the insulin-like growth factor-1 receptor alters p27 regulation by the epidermal growth factor receptor in oral squamous carcinoma cells.

Jameson MJ, Taniguchi LE, VanKoevering KK, Stuart MM, Francom CR, Mendez RE, Beckler AD, Carlson HT, Thomas CY, Khalil AA.

J Oral Pathol Med. 2013 Apr;42(4):332-8. doi: 10.1111/jop.12014. Epub 2012 Oct 26.

8.

A theory-based decision aid for patients with cancer: results of feasibility and acceptability testing of DecisionKEYS for cancer.

Hollen PJ, Gralla RJ, Jones RA, Thomas CY, Brenin DR, Weiss GR, Schroen AT, Petroni GR.

Support Care Cancer. 2013 Mar;21(3):889-99. doi: 10.1007/s00520-012-1603-8. Epub 2012 Oct 11.

9.

p16, Cyclin D1, and HIF-1α Predict Outcomes of Patients with Oropharyngeal Squamous Cell Carcinoma Treated with Definitive Intensity-Modulated Radiation Therapy.

Rahimi AS, Wilson DD, Saylor DK, Stelow EB, Thomas CY, Reibel JF, Levine PA, Shonka DC, Jameson MJ, Read PW.

Int J Otolaryngol. 2012;2012:685951. doi: 10.1155/2012/685951. Epub 2012 Jul 24.

10.

Activation of the insulin-like growth factor-1 receptor induces resistance to epidermal growth factor receptor antagonism in head and neck squamous carcinoma cells.

Jameson MJ, Beckler AD, Taniguchi LE, Allak A, Vanwagner LB, Lee NG, Thomsen WC, Hubbard MA, Thomas CY.

Mol Cancer Ther. 2011 Nov;10(11):2124-34. doi: 10.1158/1535-7163.MCT-11-0294. Epub 2011 Aug 30.

11.

Intensity-modulated radiotherapy outcomes for oropharyngeal squamous cell carcinoma patients stratified by p16 status.

Shoushtari A, Meeneghan M, Sheng K, Moskaluk CA, Thomas CY, Reibel JF, Levine PA, Jameson MJ, Keene K, Read PW.

Cancer. 2010 Jun 1;116(11):2645-54. doi: 10.1002/cncr.25040.

12.

Predicting residual neck disease in patients with oropharyngeal squamous cell carcinoma treated with radiation therapy: utility of p16 status.

Shonka DC Jr, Shoushtari AN, Thomas CY, Moskaluk C, Read PW, Reibel JF, Levine PA, Jameson MJ.

Arch Otolaryngol Head Neck Surg. 2009 Nov;135(11):1126-32. doi: 10.1001/archoto.2009.153.

PMID:
19917926
13.

Phase I study of capecitabine, carboplatin and intensity-modulated radiation therapy for head and neck cancer.

Thomas CY, Read P, Petroni G, Reibel J, Levine PA.

Anticancer Res. 2009 Jul;29(7):2869-73.

14.

Collaboration of RON and epidermal growth factor receptor in human bladder carcinogenesis.

Thomas CY, Theodorescu D.

J Urol. 2006 Nov;176(5):1909-10. No abstract available.

PMID:
17070208
15.

Molecular markers of prognosis and novel therapeutic strategies for urothelial cell carcinomas.

Thomas CY, Theodorescu D.

World J Urol. 2006 Nov;24(5):565-78. Review. No abstract available.

PMID:
17063322
16.

Esthesioneuroblastoma: continued follow-up of a single institution's experience.

Loy AH, Reibel JF, Read PW, Thomas CY, Newman SA, Jane JA, Levine PA.

Arch Otolaryngol Head Neck Surg. 2006 Feb;132(2):134-8.

PMID:
16490869
17.

Spontaneous activation and signaling by overexpressed epidermal growth factor receptors in glioblastoma cells.

Thomas CY, Chouinard M, Cox M, Parsons S, Stallings-Mann M, Garcia R, Jove R, Wharen R.

Int J Cancer. 2003 Mar 10;104(1):19-27.

18.

Toward the survival of private healthcare delivery.

Thomas CY Jr.

Mo Med. 1999 Oct;96(10):485-8.

PMID:
10528497
21.
22.
23.

Generation and pathogenicity of an NB-tropic SL3-3 murine leukemia virus.

Thomas CY, Nuckols JD, Murphy C, Innes D.

Virology. 1993 Apr;193(2):1013-7.

PMID:
8384741
24.

Candida prosthetic arthritis: report of a case treated with fluconazole and review of the literature.

Tunkel AR, Thomas CY, Wispelwey B.

Am J Med. 1993 Jan;94(1):100-3. Review.

PMID:
8420285
25.
26.

Immunoglobulin gene rearrangement in abnormal lymph node hyperplasia.

Williams ME, Lee JT, Innes DJ, Swerdlow SH, Lovell MA, Hurtubise PE, Thomas CY.

Am J Clin Pathol. 1991 Dec;96(6):746-54.

PMID:
1746491
28.
29.

Oncogenicity and U3 region sequences of class II recombinant MuLVs of CWD mice.

Thomas CY, Coppola MA, Holland CA, Massey AC.

Virology. 1990 May;176(1):166-77.

PMID:
2158688
30.

Influence of enhancer sequences on thymotropism and leukemogenicity of mink cell focus-forming viruses.

Holland CA, Thomas CY, Chattopadhyay SK, Koehne C, O'Donnell PV.

J Virol. 1989 Mar;63(3):1284-92.

31.

Phenotypic heterogeneity of spontaneous lymphomas of CWD mice.

Thomas CY, Buxton VK, Roberts JS, Boykin BJ, Innes D.

Blood. 1989 Jan;73(1):240-7.

PMID:
2562923
32.
33.
34.
35.
36.
37.
38.

The surgical approach to obstructive problems of the transplant ureter.

Helling TS, Thomas CY Jr, Moore JD, Koontz PG Jr.

Transplant Proc. 1982 Dec;14(4):751-60. No abstract available.

PMID:
6762736
40.

Control of massive duodenal ulcer hemorrhage.

Thomas CY Jr, Fowler DL.

Mo Med. 1981 Jan;78(1):21-2. No abstract available.

PMID:
7219404
41.

Prevention and management of urologic complications following renal transplantation.

Helling TS, Alleman RE, Thomas CY Jr, Moore JD, Koontz PG Jr.

Transplant Proc. 1980 Dec;12(4):695-702. No abstract available.

PMID:
7010729
42.

Expression of leukemogenic recombinant viruses associated with a recessive gene in HRS/J mice.

Green N, Hiai H, Elder JH, Schwartz RS, Khiroya RH, Thomas CY, Tsichlis PN, Coffin JM.

J Exp Med. 1980 Aug 1;152(2):249-64.

43.

Closed loop obstruction of the stomach and duodenum, a complication of Nissen fondoplication.

Pinkerton JA Jr, Thomas CY Jr, Wilber R.

Am Surg. 1979 Aug;45(8):544. No abstract available.

PMID:
507559
44.

Platelets in thrombocythemia.

Thomas CY 4th.

Ann Intern Med. 1978 Jun;88(6):845. No abstract available.

PMID:
666150
45.

Multiple leiomyosarcomas.

Wood WG, Burch TK, Thomas CY Jr.

South Med J. 1977 Mar;70(3):381-3.

PMID:
847498
46.

Hyperbaric oxygen therapy for pyoderma gangrenosum.

Thomas CY Jr, Crouch JA, Guastello J.

Arch Dermatol. 1974 Sep;110(3):445-6. No abstract available.

PMID:
4451395
47.

Importance of pathologic staging in the surgical management of adenocarcinoma of the exocrine pancreas.

Hermreck AS, Thomas CY 4th, Friesen SR.

Am J Surg. 1974 Jun;127(6):653-7. No abstract available.

PMID:
4134052
48.

The doc's paradox.

Thomas CY Jr.

Mo Med. 1973 May;70(5):292-292D. No abstract available.

PMID:
4707414
49.

A technique for end-to-side vascular anastomosis.

Rao VP, Thomas CY Jr.

Arch Surg. 1970 Jul;101(1):91. No abstract available.

PMID:
4911677
50.

Retrograde cannulation of cephalic vein for hemodialysis.

Rao VP, Thomas CY Jr.

JAMA. 1970 Feb 2;211(5):823-4. No abstract available.

PMID:
5536568

Supplemental Content

Loading ...
Support Center